The Hidden Truth Behind Actos

Actos (Pioglitazone), manufactured by Takeda, was approved by the FDA in July 1999, as a pill to treat Type 2 diabetes. Actos is in a class of drugs known as thiazolidinediones. Since 1999, millions of prescriptions of Actos were written. Actos has been one of the top selling medications in the United States.

In September 2010, the FDA warned that Actos causes urinary bladder cancer.

The warning is the result of a ten-year study. Takeda was required to change the Actos warning label to include the risk of urinary bladder cancer. In June, 2011, the FDA warned that taking Actos for more than one year may increase the risk of bladder cancer.

Are You a Victim of Actos?

The Levensten Law Firm is lead counsel in many Actos lawsuits that are pending in federal court. We investigate and file Actos lawsuits for patients diagnosed with bladder cancer. The federal multidistrict litigation, in which many of the firm’s cases are pending, encompasses hundreds of cases against Takeda. The cases are consolidated before U.S. District Judge Rebecca Doherty in the Western District of Louisiana.

If you believe you are a victim of Actos contact our law firm for a free consultation.